CLASS II Device recall · Reported 28 Jun 2017 · FDA Enforcement Report

Proteus recalled by Ion Beam Applications

Ion Beam Applications is recalling Proteus 235, distributed in 10 states. The recall was initiated on 9 Feb 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSerial Numbers: PAT.000,PAT.003, PAT.006, PAT.107, PAT.108, PAT.109, PAT.111, PAT.112, PAT.113, PAT.114, SAT.115, SAT.116, SAT.117, SAT.119, SAT.120, SAT.122, SAT.123, SAT.126
Quantity recalled18 systems ( 10 in the US)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2592-2017
FDA event ID
77175
Recalling firm
Ion Beam Applications, Louvain La Neuve
Classification
Class II
Status
Terminated
Recall initiated
9 Feb 2017
FDA classified
19 Jun 2017
Reported
28 Jun 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

9 Feb 2017Recall initiated by company
19 Jun 2017Classified by FDA+130 days
28 Jun 2017Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

It has been observed during testing that there could be clinically non-negligible amount of dark current (a well-known physics effect observed in cyclotron) in Pencil Beam Scanning (PBS) treatment mode when system is not irradiating between layers.

Product as listed by the FDA

Proteus 235

Where it was distributed

Worldwide Distribution - US Distribution to the states of : MA, FL, VA, PA, IL, NJ, WA, TN, LA and TX., and to the countries of: Germany, South Korea, France, Czech Republic, Italy, Poland and Sweden.

FloridaIllinoisLouisianaMassachusettsNew JerseyPennsylvaniaTennesseeTexasVirginiaWashington

Questions about this recall

Is Proteus 235 recalled?

Yes. Ion Beam Applications recalled Proteus 235 on 9 Feb 2017. The recall is Class II and its status is Terminated. Recall number Z-2592-2017.

Why was it recalled?

It has been observed during testing that there could be clinically non-negligible amount of dark current (a well-known physics effect observed in cyclotron) in Pencil Beam Scanning (PBS) treatment mode when system is not irradiating between layers.

Which lots are affected?

Serial Numbers: PAT.000,PAT.003, PAT.006, PAT.107, PAT.108, PAT.109, PAT.111, PAT.112, PAT.113, PAT.114, SAT.115, SAT.116, SAT.117, SAT.119, SAT.120, SAT.122, SAT.123, SAT.126

Where was it sold?

Worldwide Distribution - US Distribution to the states of : MA, FL, VA, PA, IL, NJ, WA, TN, LA and TX., and to the countries of: Germany, South Korea, France, Czech Republic, Italy, Poland and Sweden.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ion Beam Applications

All 36

Other Other Medical Devices recalls

All 13,778